Date: 5.2.2014
Technology request: A vaccine against Bovine Leukemia Virus
Reference: TOBE20131206001
Summary: A Belgian university team developed a recombinant Bovine Leukemia Virus (BLV) with attenuated phenotype and two specific mutations. Efficacy, persistence, safety and pathogenicity make this vaccine unique. The research team is looking for collaboration with companies interested in license agreement.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
ScienceWeek - Biotechnology Science since 1997
Synthetic antibody could be key to a universal antivenom
Microbes stomp daffodils in creating valuable anti-Alzheimer\'s drug